A LEGAL PERSPECTIVE ON REGULATORY REQUIREMENTS AFFECTING THE DISCOVERY AND DEVELOPMENT OF THERAPEUTIC COMPOUNDS

被引：0
|
作者：
HUTT, PB [1 ]
机构：
[1] COVINGTON & BURLING ASSOCIATES,WASHINGTON,DC
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1993年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [31] Challenges for Requirements Development: An Industry Perspective
    Kelly, Sandra
    Keenan, Frank
    McCaffery, Fergal
    SOFTWARE PROCESS IMPROVEMENT AND CAPABILITY DETERMINATION, 2011, 155 : 217 - 220
  • [32] THE HYDROPOWER DEVELOPMENT BOOM - A LEGAL PERSPECTIVE
    CLARKE, DH
    FEDERAL BAR NEWS & JOURNAL, 1982, 29 (9-10): : 331 - 336
  • [33] A therapeutic jurisprudence perspective on legal responses to medical error
    Dauer, EA
    JOURNAL OF LEGAL MEDICINE, 2003, 24 (01) : 37 - 50
  • [34] Legal and Regulatory Development of Nuclear Energy in Bangladesh
    Karim, Ridoan
    Muhammad-Sukki, Firdaus
    Karim, Mohammad Ershadul
    Munir, Abu Bakar
    Sifat, Imtiaz Mohammad
    Abu-Bakar, Siti Hawa
    Bani, Nurul Aini
    Muhtazaruddin, Mohd Nabil
    ENERGIES, 2018, 11 (10)
  • [35] Discovery and development of therapeutic cancer vaccines
    Acres, Bruce
    Limacher, Jean-Marc
    Bonnefoy, Jean-Yves
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (02) : 185 - 192
  • [36] DISCOVERY OF ER STRESS-INDUCING COMPOUNDS FOR GBM: A PROMISING APPROACH TOWARDS THERAPEUTIC DEVELOPMENT
    Veliz, Eduardo
    Sansalone, Lorenzo
    Maldonado, Amanda
    Leblanc, Roger
    Steven, Vanni
    Graham, Regina
    NEURO-ONCOLOGY, 2023, 25
  • [37] THE IMPACT OF TMI-2 ON REGULATORY REQUIREMENTS - AN INDUSTRY PERSPECTIVE
    TAYLOR, JH
    TRANSACTIONS OF THE AMERICAN NUCLEAR SOCIETY, 1980, 34 (JUN): : 595 - 596
  • [38] Requirements for generic anti-epileptic medicines: a regulatory perspective
    Maliepaard, Marc
    Hekster, Yechiel A.
    Kappelle, Arnoud
    van Puijenbroek, Eugene P.
    Elferink, Andre J.
    Welink, Jan
    Gispen-de Wied, Christine C.
    Lekkerkerker, Frits J. F.
    JOURNAL OF NEUROLOGY, 2009, 256 (12) : 1966 - 1971
  • [39] Requirements for generic anti-epileptic medicines: a regulatory perspective
    Marc Maliepaard
    Yechiel A. Hekster
    Arnoud Kappelle
    Eugène P. van Puijenbroek
    André J. Elferink
    Jan Welink
    Christine C. Gispen-de Wied
    Frits J. F. Lekkerkerker
    Journal of Neurology, 2009, 256 : 1966 - 1971
  • [40] Interpreting clinical trial data from a legal/regulatory perspective
    Brushwood, D
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 383 - 383
12345